ArticleCancer management and research2021

Fibrinogen-Albumin Ratio Index (FARI) as a Certain Prognostic Biomarker in Pretreated Patients with Immunotherapy.

Ziwei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.